1. Home
  2. RCUS vs ADX Comparison

RCUS vs ADX Comparison

Compare RCUS & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.65

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Adams Diversified Equity Fund Inc.

ADX

Adams Diversified Equity Fund Inc.

HOLD

Current Price

$25.27

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
ADX
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.9B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
RCUS
ADX
Price
$23.65
$25.27
Analyst Decision
Buy
Analyst Count
10
0
Target Price
$31.90
N/A
AVG Volume (30 Days)
798.2K
230.3K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$247,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$45.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.92
$20.32
52 Week High
$28.72
$25.35

Technical Indicators

Market Signals
Indicator
RCUS
ADX
Relative Strength Index (RSI) 47.03 64.18
Support Level $22.61 $22.73
Resistance Level $24.33 $25.30
Average True Range (ATR) 1.05 0.29
MACD -0.17 -0.00
Stochastic Oscillator 34.06 88.17

Price Performance

Historical Comparison
RCUS
ADX

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

About ADX Adams Diversified Equity Fund Inc.

Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector-neutral approach. The fund has a diversified equity portfolio that consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.

Share on Social Networks: